Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission.

Eur J Haematol · 2025 · PMC11880982 · PMID 39740005

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

Non‐relapse‐related mortality (NRM) was higher in the alloSCT group compared to the intensive consolidation group, 23% versus 7%, respectively; however, this did not reach statistical significance ( p = 0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.